http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017530183-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
filingDate 2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2017530183-A
titleOfInvention N-pyridinylacetamide derivatives as inhibitors of WNT signaling pathway
abstract The present invention relates to compounds. More specifically, the present invention relates to compounds useful as inhibitors of the Wnt signaling pathway. Specifically, the present invention contemplates inhibitors of Porcupine (Porcn). In addition, the present invention contemplates methods of preparing the compounds and uses of the compounds. Thus, the compounds of the present invention treat conditions mediated by the Wnt signaling pathway, such as cancer, sarcoma, melanoma, skin cancer, blood tumor, lymphoma, carcinoma, and leukemia; or anti-cancer therapy Can be used to enhance effectiveness.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7184383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021512861-A
priorityDate 2014-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012519210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006518738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013130364-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466379340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121273524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121280549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432743161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121280466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121280546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121280437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121280464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121273540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409306342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429057469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429056987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429056951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468251214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429056976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429056960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147884367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409043806

Total number of triples: 87.